KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Common Equity (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Common Equity for 11 consecutive years, with $293.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 66.69% year-over-year to $293.6 million, compared with a TTM value of $293.6 million through Sep 2025, down 66.69%, and an annual FY2024 reading of $825.5 million, up 47.7% over the prior year.
  • Common Equity was $293.6 million for Q3 2025 at Medpace Holdings, up from $172.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $952.9 million in Q4 2021 and bottomed at $172.4 million in Q2 2025.
  • Average Common Equity over 5 years is $587.2 million, with a median of $593.6 million recorded in 2025.
  • The sharpest move saw Common Equity skyrocketed 95.26% in 2024, then tumbled 77.43% in 2025.
  • Year by year, Common Equity stood at $952.9 million in 2021, then crashed by 59.45% to $386.4 million in 2022, then surged by 44.66% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then crashed by 64.43% to $293.6 million in 2025.
  • Business Quant data shows Common Equity for MEDP at $293.6 million in Q3 2025, $172.4 million in Q2 2025, and $593.6 million in Q1 2025.